Inhibition of simian immunodeficiency virus (SIV) replication by CD8+ T lymphocytes from macaques immunized with live attenuated SIV

Journal of Virology

Volumn 72, Issue 8, 1998, Pages 6315-6324

  Gauduin, Marie Claire ^a   Glickman, Rhona L ^a   Means, Robert ^a   Johnson, R Paul ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0031927032     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.8.6315-6324.1998     Document Type: Article

References (59)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
2. Alkhatib, G., F. Liao, K. W. C. Peden, E. A. Berger, and J. M. Farber. 1997. A new SIV co-receptor, STRL33. Nature 388:238.
3. Allen, T. M., J. Sidney, M.-F. Del Guercio, R. Glickman, G. Lensmeyer, D. Wiebe, C. Pauza, R. P. Johnson, A. Sette, and D. I. Watkins. Characterization of the peptide binding motif of a rhesus MHC Class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from SIV. J. Immunol., in press.
4. Baier, M., A. Werner, N. Bannert, K. Metzner, and R. Kurth. 1995. HIV suppression by interleukin-16. Nature 378:563.
5. Brinchmann, J. E., G. Gaudernack, and F. Vartdal. 1990. CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor. J. Immunol. 144:2961-2966.
6. Chen, Z., P. Zhou, D. D. Ho, N. R. Landau, and P. A. Marx. 1997. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:2705-2714.
7. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. P. D., L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
8. Clapham, P. R., and R. A. Weiss. 1997. Spoilt for choice of co-receptors. Nature 388:230-231.
9. Clerici, M., C. Balotta, and M. Galli. 1996. Soluble HIV suppressive factors: more than one Holy Grail? Immunol. Today 17:297.
10. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
11. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
12. Deng, H., D. Unutmaz, V. N. KewalRamani, and D. R. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300.
13. Dittmer, U., T. Nisslein, W. Bodemer, H. Petry, U. Sauermann, H. C. Stahl, and G. Hunsmann. 1995. Cellular immune response of rhesus monkeys infected with a partially attenuated net deletion mutant of the simian immunodeficiency virus. Virology 212:392-397.
14. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. S. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxon. 1990. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
15. Dulbecco, R. 1988. Virology, p. 22-25. J. P. Lippincott, Philadelphia, Pa.
16. + cytotoxic T lymphocytes from an SIV-infected rhesus macaque. J. Virol. 68: 2756-2759.
17. Farzan, M., H. Choe, K. Martin, L. Marcon, W. Hofmann, G. Karlsson, Y. Sun, P. Barrett, N. Marchand, N. Sullivan, N. Gerard, G. Gerard, and J. Sodroski. 1997. Two orphan seven-transmembrane segment receptors which arc expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:405-411.
18. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G-protein-coupled receptor. Science (Washington, D.C.) 272:872-877.
19. + nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1:1167-1173.
20. Glickman, R., and P. Johnson. Unpublished data.
21. Ho, D. D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625.
22. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
23. Johnson, R. P., R. L. Glickman, J. Q. Yang, A. Kaur, J. T. Dion, M. J. Mulligan, and R. C. Desrosiers. 1997. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J. Virol. 71:7711-7718.
24. + T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J. Virol. 64:3399-3406.
25. Kaur, A., R. Glickman, and R. P. Johnson. Unpublished data.
26. Kawai, T., J. Wong, J. MacLean, A. B. Cosimi, and S. Wee. 1994. Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. Transplant. Proc. 26:1845-1846.
27. Kestler, H., T. Kodama, D. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. Sehgal, M. Daniel, N. King, and R. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
28. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. D. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
29. Kirchhoff, F., S. Pohlmann, M. Hamacher, R. E. Means, T. Kraus, K. Uberla, and P. D. Marzio. 1997. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J. Virol. 71:6509-6516.
30. Koup, R. A., and D. D. Ho. 1990. Quantitative culture assay for HIV-1 in peripheral blood, p. 107-112. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York, N.Y.
31. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
32. Landay, A. L., C. E. Mackewicz, and J. A. Levy. 1993. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:106-116.
33. Lehner, T., Y. Wang, M. Cranage, L. A. Bergmeier, E. Mitchell, L. Tao, G. Hall, M. Dennis, N. Cook, R. Brookes, L. Klavinskis, I. Jones, C. Doyle, and R. Ward. 1996. Protective mucosal immunity elicited by targeted iliac lymph node immunization with subunit SIV envelope and core vaccine in macaques. Nat. Med. 2:767-775.
34. Levy, J. A., C. E. Mackewicz, and E. Barker. 1996. Controlling HIV pathogenesis: the role of noncytotoxic anti-HIV activity of CD8+ T cells. Immunol. Today 17:217-224.
35. Liao, F., G. Alkhatib, K. W. C. Peden, G. Sharma, E. A. Berger, and J. M. Farber. 1997. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185:2015-2023.
36. + T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69:3712-3720.
37. Mackewicz, C., and J. A. Levy. 1992. CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res. Hum. Retroviruses 8:1039-1050.
38. Mackewicz, C. E., H. Ortega, and J. A. Levy. 1994. Effect of cytokines on HIV replication in CD4+ T lymphocytes: lack of identity with the CD8+ cell antiviral factor. Cell Immunol. 153:329-343.
39. Mackewicz, C. E., H. W. Ortega, and J. A. Levy. 1991. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest. 87:1462-1466.
40. Mackewicz, C. E., L. C. Yang, J. D. Lifson, and J. A. Levy. 1994. Noncytolytic CD8+ T cells anti-HIV responses in primary HIV-1 infection. Lancet 344:1671-1673.
41. Marcon, L., H. Choe, K. A. Martin, M. Farzan, P. D. Ponath, L. Wu, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1997. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J. Virol. 71:2522-2527.
42. McMichael, A. J., and B. D. Walker. 1994. Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 8:S155-S173.
43. Means, R. E., T. Greenough, and R. C. Desrosiers. 1997. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J. Virol. 71:7895-7902.
44. Miller, M. D., C. I. Lord, V. Stallard, G. P. Mazzara, and N. L. Letvin. 1990. The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency vims of macaques. J. Immunol. 144:122-128.
45. Pal, R., A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, and A. L. DeVico. 1997. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 278:695-698.
46. Paliard, X., A. Y. Lee, and C. M. Walker. 1996. RANTES, MIP-1α and MIP-1β are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clones. AIDS 10:1317-1321.
47. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
48. Scala, E., G. D'Offizi, R. Rosso, O. Turriziana, R. Ferrara, A. M. Mazzone, G. Antonelli, F. Aiuti, and R. Paganelli. 1997. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J. Immunol. 158:4485-4492.
49. Schnittman, S. M., M. C. Psallidopoulos, H. C. Lane, T. Thompson, M. Baseler, F. Massari, C. H. Fox, N. P. Salzman, and A. S. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305-308.
50. Tsubota, H., C. I. Lord, D. I. Watkins, C. Morimoto, and N. L. Letvin. 1989. A cytotoxic T lymphocyte inhibits AIDS virus replication in peripheral blood lymphocytes. J. Exp. Med. 169:1421-1434.
51. U.S. Department of Health and Human Services. 1985. Guide for the care and use of laboratory animals. DHHS publication no. (NIH) 85-23. U.S. Government Printing Office, Washington, D.C.
52. Villinger, F. Personal communication.
53. + cells involves a noncytolytic mechanism. J. Virol. 65:5921-5927.
54. Walker, C. M., D. J. Moody, D. P. Stites, and J. A. Levy. 1986. CD8+ lymphocytes can control HIV replication in vitro by suppressing virus replication. Science 234:1563-1566.
55. Walker, M. C., and J. A. Levy. 1989. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 66:62-630.
56. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
57. Xu, X.-N., G. R. Screaton, F. M. Gotch, T. Dong, R. Tan, N. Almond, B. Walker, R. Stebbings, K. Kent, S. Nagata, J. E. Stott, and A. J. McMichael. 1997. Evasion of CTL responses by nef-dependent induction of fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186:7-16.
58. + cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:3120-3128.
59. Yang, O. O., and B. D. Walker. 1997. CD8+ cells in human immunodeficiency virus type 1 pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:273-311.